RNA – avidity biosciences, inc. (US:NASDAQ)
Stock Stats
News
Avidity Biosciences (NASDAQ:RNA) was downgraded by analysts at Evercore ISI from a "strong-buy" rating to a "hold" rating.
Avidity Biosciences (NASDAQ:RNA) was given a new $72.00 price target on by analysts at Evercore ISI.
Assessing Avidity Biosciences (RNA) Valuation After a 130% Year-to-Date Share Price Surge [Yahoo! Finance]
Dyne upgraded at Oppenheimer on upcoming trial readout from Avidity [Seeking Alpha]
Avidity Biosciences, Inc. (RNA): A Bull Case Theory [Yahoo! Finance]
Form PRER14A Avidity Biosciences,
Form 4 Avidity Biosciences, For: Dec 19 Filed by: LEVIN ARTHUR A
Form DEFA14A Avidity Biosciences,
Form 4 Avidity Biosciences, For: Dec 17 Filed by: Calderaro Charles III
Form 4 Avidity Biosciences, For: Dec 17 Filed by: Flanagan W. Michael
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.